Christopher E. Rudd
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Christopher E. Rudd has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Monika Raab
Division of Tumor Immunology, Department of Cancer Immunology and AIDS, Harvard Medical School , Boston, MA 02115
3 shared publicationsStine-Kathrein Kraeft
Division of Tumor Immunology, Departments of Cancer Immunology and AIDS and §Cancer Biology, Dana–Farber Cancer Institute, and Departments of ‡Medicine and †Pathology, Harvard Medical School, Boston MA 02115-6084; and §§Department of Haematology, Faculty of Medicine, Imperial College School of Medicine, Hammersmith Campus, Du Cane Road, London W12 0NN, United Kingdom
3 shared publicationsAntonio J. da Silva
From the Departments of ‡Cancer Immunology and AIDS and ‖Cancer Biology, Dana-Farber Cancer Institute and Departments of §§Medicine and §Pathology, Harvard Medical School, Boston, Massachusetts 02115 and the Departments of **Pathology and ‡Obstetrics and Gynecology and Reproductive Biology, Brigham and Women’s Hospital, Boston, Massachusetts 02115
2 shared publicationsHelga Schneider
Departments of Pathology and Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA
2 shared publicationsHyun Kang
Dana-Farber Cancer Institute and Departments of Medicine, Pathology and Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston MA 02115, USA
2 shared publicationsLiping Geng
Division of Tumor Immunology, Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston MA 02115-6084, USA
2 shared publications
Latest Publications
- 1 December 2001
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 289 (5) , 1135-1140
Adaptor ADAP (Adhesion- and Degranulation-Promoting Adaptor Protein) Regulates β1 Integrin Clustering on Mast Cells
- 1 December 2001
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 289 (5) , 1135-1140
Adaptor ADAP (Adhesion- and Degranulation-Promoting Adaptor Protein) Regulates β1 Integrin Clustering on Mast Cells
- Open Access
- 11 September 2001
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 98 (20) , 11527-11532
Adaptor FYB (Fyn-binding protein) regulates integrin-mediated adhesion and mediator release: Differential involvement of the FYB SH3 domain
Aggregation of the high-affinity IgE receptor (FcɛRI) on mast cells activates a tyrosine phosphorylation cascade that is required for adhesion and degranulation events leading to the release of histamine and other inflammatory mediators. The full range of intracellular mediators that regulate this process is unknown. Recent studies have identified a group of immune cell-specific adaptor proteins that include linker for activation of T-cell (LAT), SH2-domain-containing leukocyte protein (SLP-76), and Fyn-T-binding protein (FYB)/SLP-76-associated protein (SLAP). In this study, we demonstrate that FYB can up-regulate integrin-mediated adhesion to fibronectin and mediator release in RBL-2H3 mast cells. The regulation of these two events could be distinguished from each other by the requirement of the FYB SH3 domain in β-hexosaminidase release, but not adhesion, and the up-regulation of mediator release by FYB in nonadherent cells. FcɛRI aggregation increased FYB tyrosine phosphorylation, whereas confocal immunofluorescence microscopy showed that FYB colocalizes with F-actin in membrane ruffles and plaques. Our findings identify FYB as a regulator of integrin-mediated adhesion and degranulation events, which, in the case of mast cells, has potential applications to inflammatory and allergic responses.
- 11 September 2001
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 98 (20) , 11527-11532
Open AccessAdaptor FYB (Fyn-binding protein) regulates integrin-mediated adhesion and mediator release: Differential involvement of the FYB SH3 domain
Aggregation of the high-affinity IgE receptor (FcɛRI) on mast cells activates a tyrosine phosphorylation cascade that is required for adhesion and degranulation events leading to the release of histamine and other inflammatory mediators. The full range of intracellular mediators that regulate this process is unknown. Recent studies have identified a group of immune cell-specific adaptor proteins that include linker for activation of T-cell (LAT), SH2-domain-containing leukocyte protein (SLP-76), and Fyn-T-binding protein (FYB)/SLP-76-associated protein (SLAP). In this study, we demonstrate that FYB can up-regulate integrin-mediated adhesion to fibronectin and mediator release in RBL-2H3 mast cells. The regulation of these two events could be distinguished from each other by the requirement of the FYB SH3 domain in β-hexosaminidase release, but not adhesion, and the up-regulation of mediator release by FYB in nonadherent cells. FcɛRI aggregation increased FYB tyrosine phosphorylation, whereas confocal immunofluorescence microscopy showed that FYB colocalizes with F-actin in membrane ruffles and plaques. Our findings identify FYB as a regulator of integrin-mediated adhesion and degranulation events, which, in the case of mast cells, has potential applications to inflammatory and allergic responses.
- 5 June 2001
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 2001 (85) , pe1
Lnk Adaptor: Novel Negative Regulator of B Cell Lymphopoiesis
Originally thought to have the functions now ascribed to the linker for activation of T cells protein (LAT), Lnk is coming into its own as an adaptor protein that mediates signaling through several receptor pathways. An essential role for Lnk in B cell development and maturation was recently uncovered by Perlmutter and colleagues. Rudd discusses the role of Lnk in B cells and hypothesizes a mechanism whereby Lnk, and its closely related protein family members, the adaptor molecules containing pleckstrin homology (PH) and Src-homology 2 (SH2) domains (APS), and Src-homology 2-B protein (SH2-B), may mediate signal promotion or attenuation.
- 5 June 2001
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 2001 (85) , pe1
Lnk Adaptor: Novel Negative Regulator of B Cell Lymphopoiesis
Originally thought to have the functions now ascribed to the linker for activation of T cells protein (LAT), Lnk is coming into its own as an adaptor protein that mediates signaling through several receptor pathways. An essential role for Lnk in B cell development and maturation was recently uncovered by Perlmutter and colleagues. Rudd discusses the role of Lnk in B cells and hypothesizes a mechanism whereby Lnk, and its closely related protein family members, the adaptor molecules containing pleckstrin homology (PH) and Src-homology 2 (SH2) domains (APS), and Src-homology 2-B protein (SH2-B), may mediate signal promotion or attenuation.
- Open Access
- 15 February 2001
- Published by American Society of Hematology in Blood
- Vol. 97 (4) , 1134-1137
CTLA-4 blockade of antigen-induced cell death
While cytotoxic T lymphocyte antigen–4 (CTLA-4) negatively regulates T-cell receptor (TCR)–driven interleukin (IL)–2 production and proliferation, little is known regarding whether the coreceptor has the capacity to inhibit other events, such as Fas ligand (FasL) expression and antigen-induced cell death (AICD). In this study, it is shown that CTLA-4 expressed in a T-cell hybridoma can elicit a potent block of FasL expression and AICD. Inhibition occurred independently of CTLA-4 blockage of IL-2 production and was partially reversed by a single mutation in the cytoplasmic YVKM motif. These findings indicate that CTLA-4 can block TCR signaling prior to bifurcation of signals leading to IL-2 production and apoptosis.
- 15 February 2001
- Published by American Society of Hematology in Blood
- Vol. 97 (4) , 1134-1137
Open AccessCTLA-4 blockade of antigen-induced cell death
While cytotoxic T lymphocyte antigen–4 (CTLA-4) negatively regulates T-cell receptor (TCR)–driven interleukin (IL)–2 production and proliferation, little is known regarding whether the coreceptor has the capacity to inhibit other events, such as Fas ligand (FasL) expression and antigen-induced cell death (AICD). In this study, it is shown that CTLA-4 expressed in a T-cell hybridoma can elicit a potent block of FasL expression and AICD. Inhibition occurred independently of CTLA-4 blockage of IL-2 production and was partially reversed by a single mutation in the cytoplasmic YVKM motif. These findings indicate that CTLA-4 can block TCR signaling prior to bifurcation of signals leading to IL-2 production and apoptosis.
- Open Access
- 15 June 2000
- Published by Springer Nature in The EMBO Journal
- Vol. 19 (12) , 2889-2899
SH3 domain recognition of a proline‐independent tyrosine‐based RKxxYxxY motif in immune cell adaptor SKAP55
Src‐homology 3 (SH3) domains recognize PXXP core motif preceded or followed by positively charged residue(s). Whether SH3 domains recognize motifs other than proline‐based sequences is unclear. In this study, we report SH3 domain binding to a novel proline‐independent motif in immune cell adaptor SKAP55, which is comprised of two N‐terminal lysine and arginine residues followed by two tyrosines (i.e. RKxxYxxY). Domains capable of binding to class I proline motifs bound to the motif, while the class II domains failed to bind. Peptide precipitation, alanine scanning and in vivo co‐expression studies demonstrated a requirement for the arginine, lysine and tandem tyrosines of the motif. Two‐dimensional NMR analysis of the peptide bound FYN‐SH3 domain showed overlap with the binding site of a proline‐rich peptide on the charged surface of the SH3 domain, while resonance signals for other residues (W119, W120, Y137) were not perturbed by the RKGDYASY based peptide. Expression of the RKGDYASY peptide potently inhibited TcRζ/CD3‐mediated NF‐AT transcription in T cells. Our findings extend the repertoire of SH3 domain binding motifs to include a tyrosine‐based motif and demonstrate a regulatory role for this motif in receptor signaling.
- 15 June 2000
- Published by Springer Nature in The EMBO Journal
- Vol. 19 (12) , 2889-2899
Open AccessSH3 domain recognition of a proline‐independent tyrosine‐based RKxxYxxY motif in immune cell adaptor SKAP55
Src‐homology 3 (SH3) domains recognize PXXP core motif preceded or followed by positively charged residue(s). Whether SH3 domains recognize motifs other than proline‐based sequences is unclear. In this study, we report SH3 domain binding to a novel proline‐independent motif in immune cell adaptor SKAP55, which is comprised of two N‐terminal lysine and arginine residues followed by two tyrosines (i.e. RKxxYxxY). Domains capable of binding to class I proline motifs bound to the motif, while the class II domains failed to bind. Peptide precipitation, alanine scanning and in vivo co‐expression studies demonstrated a requirement for the arginine, lysine and tandem tyrosines of the motif. Two‐dimensional NMR analysis of the peptide bound FYN‐SH3 domain showed overlap with the binding site of a proline‐rich peptide on the charged surface of the SH3 domain, while resonance signals for other residues (W119, W120, Y137) were not perturbed by the RKGDYASY based peptide. Expression of the RKGDYASY peptide potently inhibited TcRζ/CD3‐mediated NF‐AT transcription in T cells. Our findings extend the repertoire of SH3 domain binding motifs to include a tyrosine‐based motif and demonstrate a regulatory role for this motif in receptor signaling.
- 1 May 2000
- Published by Elsevier in Current Biology
- Vol. 10 (9) , R344-R347
Lymphocyte signaling: Cbl sets the threshold for autoimmunity
- 1 May 2000
- Published by Elsevier in Current Biology
- Vol. 10 (9) , R344-R347
Lymphocyte signaling: Cbl sets the threshold for autoimmunity
- Open Access
- 1 December 1999
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 163 (11) , 5753-5757
Cutting Edge: SLP-76 Cooperativity with FYB/FYN-T in the Up-Regulation of TCR-Driven IL-2 Transcription Requires SLP-76 Binding to FYB at Tyr595 and Tyr651
SLP-76 (Src homology (SH) 2-domain-containing leukocyte protein of 76 kDa) and FYB/SLAP (FYN-T-binding protein/SLP-76-associated protein) are two hemopoietic cell-specific adaptor proteins downstream of TCR-activated protein tyrosine kinases. SLP-76 has been implicated as an essential component in T cell signaling. FYB is selectively phosphorylated by FYN-T, providing a template for the recruitment of FYN-T and SLP-76 SH2 domains. Coexpression of FYN-T, FYB, and SLP-76 can synergistically up-regulate IL-2 production in T cells upon TCR ligation. In this report, we show that two tyrosines, Tyr595 and Tyr651, of FYB are major sites of phosphorylation by FYN-T and mediate binding to SLP-76 in Jurkat T cells. Furthermore, the synergistic up-regulation of IL-2 promoter activity in the FYN-T-FYB-SLP-76 pathway is contingent upon the interaction between FYB and SLP-76, but not the interaction between FYB and FYN-T. These observations define a pathway by which SLP-76 interacts with downstream components in the up-regulation of T cell cytokine production.
- 1 December 1999
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 163 (11) , 5753-5757
Open AccessCutting Edge: SLP-76 Cooperativity with FYB/FYN-T in the Up-Regulation of TCR-Driven IL-2 Transcription Requires SLP-76 Binding to FYB at Tyr595 and Tyr651
SLP-76 (Src homology (SH) 2-domain-containing leukocyte protein of 76 kDa) and FYB/SLAP (FYN-T-binding protein/SLP-76-associated protein) are two hemopoietic cell-specific adaptor proteins downstream of TCR-activated protein tyrosine kinases. SLP-76 has been implicated as an essential component in T cell signaling. FYB is selectively phosphorylated by FYN-T, providing a template for the recruitment of FYN-T and SLP-76 SH2 domains. Coexpression of FYN-T, FYB, and SLP-76 can synergistically up-regulate IL-2 production in T cells upon TCR ligation. In this report, we show that two tyrosines, Tyr595 and Tyr651, of FYB are major sites of phosphorylation by FYN-T and mediate binding to SLP-76 in Jurkat T cells. Furthermore, the synergistic up-regulation of IL-2 promoter activity in the FYN-T-FYB-SLP-76 pathway is contingent upon the interaction between FYB and SLP-76, but not the interaction between FYB and FYN-T. These observations define a pathway by which SLP-76 interacts with downstream components in the up-regulation of T cell cytokine production.
- Open Access
- 1 October 1999
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (40) , 28427-28435
Novel Isoform of Lymphoid Adaptor FYN-T-binding Protein (FYB-130) Interacts with SLP-76 and Up-regulates Interleukin 2 Production
- 1 October 1999
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (40) , 28427-28435
Open AccessNovel Isoform of Lymphoid Adaptor FYN-T-binding Protein (FYB-130) Interacts with SLP-76 and Up-regulates Interleukin 2 Production
- Open Access
- 15 August 1999
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 163 (4) , 1868-1879
Cytolytic T Lymphocyte-Associated Antigen-4 and the TCRζ/CD3 Complex, But Not CD28, Interact with Clathrin Adaptor Complexes AP-1 and AP-2
The negative signaling receptor cytolytic T lymphocyte-associated Ag-4 (CTLA-4) resides primarily in intracellular compartments such as the Golgi apparatus of T cells. However, little is known regarding the molecular mechanisms that influence this accumulation. In this study, we demonstrate binding of the clathrin adaptor complex AP-1 with the GVYVKM motif of the cytoplasmic domain of CTLA-4. Binding occurred primarily in the Golgi compartment of T cells, unlike with AP-2 binding that occurs mostly with cell surface CTLA-4. Although evidence was not found to implicate AP-1 binding in the retention of CTLA-4 in the Golgi, AP-1 appears to play a role in shuttling of excess receptor from the Golgi to the lysosomal compartments for degradation. In support of this, increased CTLA-4 synthesis resulted in an increase in CTLA-4/AP-1 binding and a concomitant increase in the appearance of CTLA-4 in the lysosomal compartment. At the same time, the level of intracellular receptor was maintained at a constant level, suggesting that CTLA-4/AP-1 binding represents one mechanism to ensure steady state levels of intracellular CTLA-4 in T cells. Finally, we demonstrate that the TCRζ/CD3 complex (but not CD28) also binds to AP-1 and AP-2 complexes, thus providing a possible link between these two receptors in the regulation of T cell function.
- 15 August 1999
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 163 (4) , 1868-1879
Open AccessCytolytic T Lymphocyte-Associated Antigen-4 and the TCRζ/CD3 Complex, But Not CD28, Interact with Clathrin Adaptor Complexes AP-1 and AP-2
The negative signaling receptor cytolytic T lymphocyte-associated Ag-4 (CTLA-4) resides primarily in intracellular compartments such as the Golgi apparatus of T cells. However, little is known regarding the molecular mechanisms that influence this accumulation. In this study, we demonstrate binding of the clathrin adaptor complex AP-1 with the GVYVKM motif of the cytoplasmic domain of CTLA-4. Binding occurred primarily in the Golgi compartment of T cells, unlike with AP-2 binding that occurs mostly with cell surface CTLA-4. Although evidence was not found to implicate AP-1 binding in the retention of CTLA-4 in the Golgi, AP-1 appears to play a role in shuttling of excess receptor from the Golgi to the lysosomal compartments for degradation. In support of this, increased CTLA-4 synthesis resulted in an increase in CTLA-4/AP-1 binding and a concomitant increase in the appearance of CTLA-4 in the lysosomal compartment. At the same time, the level of intracellular receptor was maintained at a constant level, suggesting that CTLA-4/AP-1 binding represents one mechanism to ensure steady state levels of intracellular CTLA-4 in T cells. Finally, we demonstrate that the TCRζ/CD3 complex (but not CD28) also binds to AP-1 and AP-2 complexes, thus providing a possible link between these two receptors in the regulation of T cell function.
- 1 November 1998
- Published by Elsevier in Current Biology
- Vol. 8 (22) , R805-R808
Lymphocyte signaling: Adapting new adaptors
- 1 November 1998
- Published by Elsevier in Current Biology
- Vol. 8 (22) , R805-R808
Lymphocyte signaling: Adapting new adaptors